Wednesday, November 26, 2008

Test your genes for cancer? 23andme.com

Your 23andMe scan includes genetic analysis on all of the following diseases, traits, and conditions. This list grows every month as new research is published.

Clinical Reports (23)
Clinical Reports give you information about conditions and traits for which there are genetic associations supported by multiple, large, peer-reviewed studies. Those associations must also have a substantial influence on a person's chances of developing the disease or having the trait. Because these associations are widely regarded as reliable, we use them to develop quantitative estimates and definitive explanations of what they mean for you.
Age-related Macular Degeneration
Alcohol Flush Reaction
Bitter Taste Perception
Celiac Disease
Crohn's Disease
Cystic Fibrosis (Delta F508 mutation)
Earwax Type
Eye Color
G6PD Deficiency
Lactose Intolerance
Malaria Resistance (Duffy Antigen)
Muscle Performance
Non-ABO Blood Groups
Norovirus Resistance
Parkinson's Disease
Prostate Cancer
Psoriasis
Resistance to HIV/AIDS
Rheumatoid Arthritis
Sickle Cell Anemia & Malaria Resistance
Type 1 Diabetes
Type 2 Diabetes
Venous Thromboembolism

Research Reports (72)
Research Reports give you information from research that has not yet gained enough scientific consensus to be included in our Clinical Reports. This research is generally based on high-quality but limited scientific evidence. Because these results have not yet been demonstrated through large, replicated studies, we do not perform complete quantitative analyses of their effects. We do, however, explain how they may–if confirmed–affect your odds of having or developing a trait, condition or disease.
Research Reports also includes scientifically accepted, established research that does not have a dramatic influence on a person's risk for a disease.
Alcohol Dependence
Aneurysm
Ankylosing Spondylitis
Antidepressant Response
Asthma
Atrial Fibrillation
Attention-Deficit Hyperactivity Disorder
Avoidance of Errors
Back Pain
Baldness
Beta-Blocker Response
Bipolar Disorder
Birth Weight
Bladder Cancer
Blood Glucose
Breast Cancer
Breast Cancer
C-reactive Protein Level
Caffeine Metabolism
Celiac Disease
Chronic Lymphocytic Leukemia
Cluster Headaches
Colorectal Cancer
Creutzfeldt-Jakob Disease
Developmental Dyslexia
Endometriosis
Esophageal Cancer
Eye Color
Food Preference
Freckling
Gallstones
Glaucoma
Gout
HDL Cholesterol Level
HIV Progression
Hair Color
Heart Attack
Height
Heroin Addiction
High Blood Pressure (Hypertension)
Kidney Disease
Larynx Cancer
Longevity
Lou Gehrig's Disease (ALS)
Lung Cancer
Lupus (Systemic Lupus Erythematosus)
Male Infertility
Measures of Intelligence
Memory
Multiple Sclerosis
Neuroblastoma
Nicotine Dependence
Obesity
Obesity
Obsessive-Compulsive Disorder
Odor Detection
Oral and Throat Cancer
Osteoarthritis
Pain Sensitivity
Peripheral Arterial Disease
Persistent Fetal Hemoglobin
Placental Abruption
Pre-eclampsia
Progressive Supranuclear Palsy
Restless Legs Syndrome
Schizophrenia
Sjögren's Syndrome
Skin Cancer
Stomach Cancer
Tardive Dyskinesia
Tourette's Syndrome
Uterine Fibroids
The genotyping services of 23andMe are performed in LabCorp's CLIA-registered laboratory. The results presented in Health and Traits have not been cleared or approved by the FDA but have been analytically validated according to CLIA standards.

1 comment:

Sophia Jason said...

A new non-invasive urine test part of the new gold standard for detecting bladder cancer, called NMP22 Bladderchek. The new bladder cancer test, it takes only an hour and can give accurate test results. To know more visit the website and read http://www.asiasbestdoctors.com/story_445.html